483
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA 483, Sep 1, 2023
Record Details
An FDA inspection of Grifols Therapeutics LLC in Clayton, NC, identified several significant deficiencies in their biologic drug manufacturing operations. Key issues included inadequate control over production processes, failures in equipment preventive maintenance, and a lack of established written procedures for critical tasks. Additionally, the facility exhibited poor maintenance of freezers and insufficient control of utility support systems.
View Company Profile
ID · a0027827-e11c-4401-8d9e-736ea37fded6
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.